Moderate-to-severe traumatic brain injury (TBI), but not mild TBI, is associated with a significantly higher risk for malignant brain tumor, a new study showed. In a cohort that included more than 150 ...

Moderate, severe, and penetrating traumatic brain injury (TBI) is associated with an elevated risk of developing brain cancer, new research suggested. However, mild TBI appears to confer no increased ...

Of 1.9 million veterans in the study, 450,000 experienced TBI. Over a median follow-up of 7.2 years, brain cancer occurred in 318 veterans without TBI (0.02%), 80 with mild TBI (0.02%), 17 with ...

Please provide your email address to receive an email when new articles are posted on . Patients with moderate to severe aortic stenosis appear to have outcomes just as poor as those with severe ...

In September 2022, the US Food and Drug Administration (FDA) approved Sotyktu (deucravacitinib; Bristol-Myers Squibb Company), a tyrosine kinase 2 (TYK2) inhibitor, for the treatment of moderate to ...

Oral roflumilast showed significant efficacy in reducing psoriasis severity, with 63% achieving PASI less than 5 by week 24. The study reported mild gastrointestinal symptoms but no serious adverse ...